Matches in Nanopublications for { ?s ?p "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP658717.RAA2CqlXcPD3saQANYpYSvYGGgWGZjomvC4ee4EjXkkCw130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658717.RAA2CqlXcPD3saQANYpYSvYGGgWGZjomvC4ee4EjXkkCw130_provenance.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.
- NP160470.RAxYJlAcao2bXBZVDj_gLXR_lKxki8vX-i5faie5S-O_M130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160470.RAxYJlAcao2bXBZVDj_gLXR_lKxki8vX-i5faie5S-O_M130_provenance.
- NP458454.RAeZXXQGQSgVA32ZwXcijwQGKmrPHWfPPdstZ_BQ2kqSg130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458454.RAeZXXQGQSgVA32ZwXcijwQGKmrPHWfPPdstZ_BQ2kqSg130_provenance.
- NP333694.RAYcTC7vBM8TVlzT4Oxg6-iSXojuOj0-tXMMSHOf9G8mA130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333694.RAYcTC7vBM8TVlzT4Oxg6-iSXojuOj0-tXMMSHOf9G8mA130_provenance.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.
- NP333954.RAYjLObwDIKLl7HY4_6EgavhnSxqZt92HxYL_FgZjarCc130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333954.RAYjLObwDIKLl7HY4_6EgavhnSxqZt92HxYL_FgZjarCc130_provenance.
- NP333873.RADvc7Hh-mKym-QyGZXeVPjrRgaCfMMzwwXwS05LnTUUk130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333873.RADvc7Hh-mKym-QyGZXeVPjrRgaCfMMzwwXwS05LnTUUk130_provenance.
- NP1015353.RAYxoiDAmuWx5rAR8Tq5IlSIc0smjuBL5W5GuzHs53P04130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015353.RAYxoiDAmuWx5rAR8Tq5IlSIc0smjuBL5W5GuzHs53P04130_provenance.
- NP1015354.RAX0Vd_C8Sj0AHxog_j1ewXFW8G8YA3e3INX-MhnWrMec130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015354.RAX0Vd_C8Sj0AHxog_j1ewXFW8G8YA3e3INX-MhnWrMec130_provenance.